SCHEMBL7735006

SCHEMBL7735006

Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(OC(F)(F)F)C2CCSCC2)[C@@H](O)[C@H]1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHCY P23526 9/20 0.52
▸ PRMT5 O14744 1/20 0.51
▸ WDR77 Q9BQA1 1/20 0.51
▸ EHMT2 Q96KQ7 2/20 0.49
▸ EHMT1 Q9H9B1 1/20 0.49
▸ DPP4 P27487 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ SLC28A1 O00337 1/20 0.48
▸ MAP3K7 O43318 1/20 0.48
▸ SLC28A2 O43868 1/20 0.48
▸ GAPDH P04406 1/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ ADORA2A P29274 1/20 0.48
▸ ADORA2B P29275 1/20 0.48
▸ ADORA1 P30542 1/20 0.48
▸ STAT6 P42226 1/20 0.48
▸ PI4KA P42356 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7733959 0.90 AHCY (0.53) AHCYPRMT5WDR77EHMT2EHMT1
SCHEMBL7733927 0.87 AHCY (0.52) AHCYPRMT5WDR77EHMT2EHMT1
SCHEMBL7732659 0.87 AHCY (0.52) AHCYPRMT5WDR77EHMT2EHMT1
SCHEMBL7734137 0.82 AHCY (0.50) AHCYPRMT5WDR77EHMT2EHMT1
SCHEMBL7723981 0.81 EHMT1 (0.54) AHCYPRMT5WDR77EHMT2EHMT1
SCHEMBL7723990 0.80 ADORA3 (0.51) AHCYPRMT5WDR77EHMT2EHMT1
SCHEMBL7735071 0.79 AHCY (0.58) AHCYPRMT5WDR77DPP4MEN1
SCHEMBL5361659 0.79 ADORA3 (0.57) AHCYEHMT2EHMT1ADORA3MAPK1
SCHEMBL5354507 0.79 ADORA3 (0.56) AHCYEHMT2EHMT1DPP4ADORA3
SCHEMBL5349884 0.78 HSP90B1 (0.57) AHCYEHMT2EHMT1DPP4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407076-B1 ANTIISCHEMIC, ANTILIPOLYTIC, ANTICONVULSANT AND HYPOTENSIVE AGENTS; CARDIOVASCULAR AND NERVOUS SYSTEM DISORDERS; ATHEROSCLEROSIS SMITHKLINE BEECHAM CORPORATION 2002-06-18 — — US claimed
Send feedback